CVS Health Corporation (LON: 0HRS)
London
· Delayed Price · Currency is GBP · Price in USD43.96
-0.35 (-0.79%)
Dec 23, 2024, 7:12 PM BST
CVS Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 29, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 30, 2021 | Dec '20 Dec 30, 2020 | Dec '19 Dec 30, 2019 | 2018 - 2014 |
| Net Income | 5,016 | 8,344 | 4,311 | 8,001 | 7,179 | 6,634 | Upgrade
|
| Depreciation & Amortization | 4,584 | 4,366 | 4,224 | 4,486 | 4,441 | 4,371 | Upgrade
|
| Loss (Gain) From Sale of Assets | 349 | 349 | 2,058 | - | -269 | 205 | Upgrade
|
| Asset Writedown & Restructuring Costs | 688 | - | - | 1,789 | - | 231 | Upgrade
|
| Stock-Based Compensation | 530 | 588 | 447 | 484 | 400 | 453 | Upgrade
|
| Other Operating Activities | -1,015 | -236 | -1,681 | -352 | 955 | -545 | Upgrade
|
| Change in Accounts Receivable | -3,326 | -6,260 | -2,971 | -2,703 | -1,510 | -2,158 | Upgrade
|
| Change in Inventory | 283 | 1,233 | -1,435 | 735 | -973 | -1,075 | Upgrade
|
| Change in Accounts Payable | 3,321 | 3,618 | 4,260 | 2,898 | 2,769 | 3,550 | Upgrade
|
| Change in Other Net Operating Assets | -5,819 | 1,424 | 6,964 | 2,927 | 2,873 | 1,182 | Upgrade
|
| Operating Cash Flow | 4,611 | 13,426 | 16,177 | 18,265 | 15,865 | 12,848 | Upgrade
|
| Operating Cash Flow Growth | -67.32% | -17.01% | -11.43% | 15.13% | 23.48% | 44.93% | Upgrade
|
| Capital Expenditures | -2,924 | -3,031 | -2,727 | -2,520 | -2,437 | -2,457 | Upgrade
|
| Cash Acquisitions | -205 | -16,612 | -139 | -146 | -866 | -444 | Upgrade
|
| Divestitures | - | - | -1,249 | - | 840 | - | Upgrade
|
| Investment in Securities | -5,279 | -1,314 | -1,017 | -2,717 | -3,172 | -485 | Upgrade
|
| Other Investing Activities | 100 | 68 | 85 | 122 | 101 | 47 | Upgrade
|
| Investing Cash Flow | -8,308 | -20,889 | -5,047 | -5,261 | -5,534 | -3,339 | Upgrade
|
| Short-Term Debt Issued | - | 5,200 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 10,898 | - | 987 | 9,958 | 3,736 | Upgrade
|
| Total Debt Issued | 5,759 | 16,098 | - | 987 | 9,958 | 3,736 | Upgrade
|
| Short-Term Debt Repaid | - | -5,000 | - | - | - | -720 | Upgrade
|
| Long-Term Debt Repaid | - | -3,166 | -4,211 | -10,254 | -15,631 | -8,336 | Upgrade
|
| Total Debt Repaid | -2,138 | -8,166 | -4,211 | -10,254 | -15,631 | -9,056 | Upgrade
|
| Net Debt Issued (Repaid) | 3,621 | 7,932 | -4,211 | -9,267 | -5,673 | -5,320 | Upgrade
|
| Issuance of Common Stock | 377 | 277 | 551 | 549 | 264 | 210 | Upgrade
|
| Repurchase of Common Stock | -3,209 | -2,193 | -3,870 | -168 | -88 | -112 | Upgrade
|
| Common Dividends Paid | -3,314 | -3,132 | -2,907 | -2,625 | -2,624 | -2,603 | Upgrade
|
| Other Financing Activities | -13 | -201 | -79 | 155 | 425 | 171 | Upgrade
|
| Financing Cash Flow | -2,538 | 2,683 | -10,516 | -11,356 | -7,696 | -7,654 | Upgrade
|
| Net Cash Flow | -6,235 | -4,780 | 614 | 1,648 | 2,635 | 1,855 | Upgrade
|
| Free Cash Flow | 1,687 | 10,395 | 13,450 | 15,745 | 13,428 | 10,391 | Upgrade
|
| Free Cash Flow Growth | -85.07% | -22.71% | -14.58% | 17.25% | 29.23% | 52.18% | Upgrade
|
| Free Cash Flow Margin | 0.46% | 2.91% | 4.18% | 5.41% | 5.01% | 4.06% | Upgrade
|
| Free Cash Flow Per Share | 1.33 | 8.06 | 10.17 | 11.85 | 10.22 | 7.96 | Upgrade
|
| Cash Interest Paid | 2,760 | 2,418 | 2,239 | 2,469 | 2,904 | 2,954 | Upgrade
|
| Cash Income Tax Paid | 2,337 | 3,524 | 4,116 | 3,195 | 2,929 | 2,717 | Upgrade
|
| Levered Free Cash Flow | 1,958 | 11,075 | 11,935 | 14,783 | 12,871 | 10,174 | Upgrade
|
| Unlevered Free Cash Flow | 3,764 | 12,737 | 13,365 | 16,347 | 14,687 | 12,071 | Upgrade
|
| Change in Net Working Capital | 4,383 | -2,018 | -1,582 | -5,049 | -3,744 | -2,318 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.